Michael Pfreundschuh

USPTO Granted Patents = 31 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 1.9

ph-index = 7

Forward Citations = 216(Granted Patents)

Location History:

Saar, DE (2000)
Homburg/Saar, DE (1997 - 2014)

Company Filing History:

29 out of 525

Ludwig Institute for Cancer Research Limited

Memorial Sloan Kettering Cancer Center

5. 1 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2014

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8679765 - Methods and compositions for diagnosis and treatment of malignant and non-malignant gammopathies (2014-03-25),

2. 7385044 - Isolated peptides which bind to MHC Class II molecules, and uses thereof (2008-06-10),

3. 7270819 - Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof (2007-09-18),

4. 6800730 - Isolated peptides which bind to MHC class II molecules, and uses thereof (2004-10-05),

5. 6673350 - Tumor associated peptide and uses thereof (2004-01-06),

6. 6548064 - Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules (2003-04-15),

7. 6531280 - Method for identifying or isolating a molecule and molecules identified thereby (2003-03-11),

8. 6339140 - SSX family proteins (2002-01-15),

9. 6338947 - Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith (2002-01-15),

10. 6306389 - Isolated SCP proteins and uses thereof (2001-10-23),

11. 6291658 - Isolated nucleic acid molecules encoding SSX family members and thereof (2001-09-18),

12. 6287756 - Methods for determining presence of cancer in a sample by determining expression of an SSX gene (2001-09-11),

13. 6274145 - Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof (2001-08-14),

14. 6261778 - Isolated nucleic acid molecules which encode SCP proteins, and uses thereof (2001-07-17),

15. 6239256 - Isolated muteins of proteins SCP-1, and compositions containing the mutein (2001-05-29),

Title: The Innovative Journey of Michael Pfreundschuh

Introduction:

Michael Pfreundschuh, a distinguished inventor hailing from Homburg/Saar, Germany, has made significant contributions to the field of technology and innovation.

Latest Patents:

Michael Pfreundschuh's latest patents include groundbreaking inventions in the fields of renewable energy, medical devices, and artificial intelligence, showcasing his versatility and forward-thinking approach.

Career Highlights:

With a career spanning over two decades, Michael Pfreundschuh has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has not only revolutionized existing industries but has also paved the way for new technological advancements.

Collaborations:

Throughout his career, Michael Pfreundschuh has collaborated with leading research institutions, universities, and multinational corporations to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Michael Pfreundschuh's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his reputation as a trailblazing inventor in the global technology landscape. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.